Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy Clinical Trial

Official title:
A Multicenter, Open-Label, Flexible Dose Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Patients With Treatment-Resistant Childhood Absence Seizures

Status Terminated

Clinical Trial Summary

The primary purpose of this study is to assess the long-term safety and tolerability of Cannabidiol Oral Solution (CBD) in pediatric participants with treatment-resistant childhood absence seizures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03355300
Study type	Interventional
Source	Radius Pharmaceuticals, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	February 20, 2018
Completion date	June 28, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00393666` - Why Are Patients With Absence Seizures Absent? A Brain Imaging Study	N/A
Terminated	`NCT06153186` - Flunarizine for Treatment Resistant Absence Epilepsy	Phase 2
Enrolling by invitation	`NCT05109234` - A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Not yet recruiting	`NCT06315322` - A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Recruiting	`NCT04666610` - A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Completed	`NCT00088452` - Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Phase 3
Terminated	`NCT03336242` - Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures	Phase 2
Completed	`NCT00361010` - A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy	N/A
Completed	`NCT00041951` - Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study	N/A
Recruiting	`NCT06310772` - Assessing Comorbidities in Epilepsy Using Eye Movement Recordings